Introduction: immunotherapy for multiple myeloma--insights and advances
Stevenson, F.; Anderson, K.C.
Seminars in Hematology 36(1 Suppl. 3): 1-2
1999
ISSN/ISBN: 0037-1963 PMID: 9989481 Document Number: 503586
Document emailed within 1 workday
Related Documents
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175Bataille, R. 1997: New insights in the clinical biology of multiple myeloma Seminars in Hematology 34(1 Suppl 1: 23-28
Claudio, J.O.; Masih-Khan, E.; Stewart, A.K. 2004: Insights from the gene expression profiling of multiple myeloma Current Hematology Reports 3(1): 67-73
Klein, B.; Bataille, R. 1990: Advances in the biology of multiple myeloma Pathologie-Biologie 38(8): 820-821
Kurtin, S. 2011: Advances and new challenges in multiple myeloma Oncology 25(4 Suppl Nurse Ed): 33-34
Varterasian, M.L. 1995: Biologic and clinical advances in multiple myeloma Oncology 9(5): 417
Miwa, A. 2007: Advances in therapeutic strategies for multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(13): 2200-2216
Kosaka, M. 1996: Advances in the pathogenesis, biology, and management of multiple myeloma Rinsho Byori. Japanese Journal of Clinical Pathology 44(8): 743-749
Facon, T. 2006: Advances in the treatment of elderly patients with multiple myeloma Clinical Advances in Hematology and Oncology: H&o 4(7): 501-502
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Wu, M-Jei.; Fang, H-Chang.; Chang, T-Yuan.; Lo, Y-Shing.; Chung, H-Min. 2002: Multiple myeloma with myeloma nephropathy in a patient with Hashimoto's thyroiditis Journal of the Formosan Medical Association 101(6): 421-424
Aucouturier, P.; Ronco, P. 1995: New insights into the mechanisms of myeloma-associated renal diseases Annales de Medecine Interne 146(5): 290-291
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41
Woodsong, C.; MacQueen, K.; Amico, K.R.; Friedland, B.; Gafos, M.; Mansoor, L.; Tolley, E.; McCormack, S. 2013: Microbicide clinical trial adherence: insights for introduction Journal of the International Aids Society 16: 18505
Teunissen, L.L.; Notermans, N.C. 1998: The risk of Kahler disease (multiple myeloma) in patients with a paraproteinemia: myeloma risk score, developed in the region of the Integral Cancer Center, West Nederlands Tijdschrift Voor Geneeskunde 142(43): 2374-2375
Takahashi, T.; Makiguchi, Y.; Hinoda, Y.; Kakiuchi, H.; Nakagawa, N.; Imai, K.; Yachi, A. 1994: Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient Journal of Immunology 153(5): 2102-2109
Sataloff, R.T. 2004: Advances in cancer immunotherapy Ear Nose and Throat Journal 83(10): 665
Parmiani, G. 1994: Immunotherapy of tumors. Introduction Immunology Series 61: 227-230
Amiel, J.L. 1977: Chemotherapy and immunotherapy of cancer. Current advances Semaine des Hopitaux. Therapeutique 53(9): 473-474